Also from this source

04 May, 2017, 09:00 ET Immune Receives Nasdaq Letters


You just read:

Immune Pharmaceuticals Will Request an Appeal to Regain Compliance with Nasdaq's Minimum Bid Price Rule

News provided by

Immune Pharmaceuticals Inc.

09 Jan, 2017, 18:11 ET